Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201102317 Principal Investigator: Bartlett, Nancy
Title: A Randomized Phase II Study of Rituximab with ABVD Versus Standard ABVD for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor Risk Features (IPS Score > 2)
Phase: II Disease Site: Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The goal of this clinical research study is to compare the effectiveness of receiving adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) therapy alone to receiving ABVD with rituximab.

Up to 120 patients will take part in this study. Up to 10 will be enrolled at Washington University.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)